INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Corporate insider
SV

Setia Vishwas

Chief Financial OfficerCIK 0002021256

EDGAR filingsOpen in network
Disclosed transactions14
Buys / sells0 / 11
Max Insider Score39
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$131K
4,803 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    MapLight Therapeutics, Inc.Chief Financial Officer · Jan 29, 2026
16
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL
$9,607
325 sh
May 4, 2026
May 6, 2026
traded May 4, 2026
+2d
SEC FORM 4

Evidence

16
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$24K
787 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

19
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$279K
9,935 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC FORM 4

Evidence

13
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$28K
968 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC FORM 4

Evidence

16
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$238K
8,496 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC FORM 4

Evidence

16
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$60K
2,068 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC FORM 4

Evidence

22
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$254K
8,989 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

39
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$75K
2,806 sh
Apr 15, 2026Apr 17, 2026
traded Apr 15, 2026
+2dSEC FORM 4

Evidence

32
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$2,392
87 sh
Apr 16, 2026Apr 17, 2026
traded Apr 16, 2026
+1dSEC FORM 4

Evidence

32
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$783
29 sh
Apr 16, 2026Apr 17, 2026
traded Apr 16, 2026
+1dSEC FORM 4

Evidence

9
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
7,730 sh
Feb 5, 2026Feb 9, 2026
traded Feb 5, 2026
+4dSEC FORM 4

Evidence

9
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
31.4K sh
Feb 5, 2026Feb 9, 2026
traded Feb 5, 2026
+4dSEC FORM 4

Evidence

19
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Tax withholding
F$600K
33.4K sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC FORM 4

Evidence

Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago